|
ASSIST Program
|
,
Phone
:
(877)864-8437
Fax:
|
Eligibility
|
> |
Insurance status will be considered on a case by case status. Patients must meet income requirements that have not been disclosed and must reside and receive treatment in the US. |
Who Can Apply
|
> |
Patients must call for a prescreening. |
Required
|
> |
Doctors must provide patients with a prescription and patients must call to enroll. |
Supply
|
> |
Not specified |
Ship To
|
> |
Not specified |
Note
|
> |
For information on Patient Assistance Programs that may be available for United Therapeutics Corporation products (Orenitram®, Remodulin®, Tyvaso®) or Lung Biotechnology's product (Adcirca®), please contact ASSIST at 877 864-8437 |
|
Includes Support for This Drug NOTE: Linked drugs are available for Prescribers to Apply Online now. Click drug logo or drug name to start online application. |
Adcirca tablet |
Orenitram tablet; extended release |
Remodulin injection |
Tyvaso solution; inhalation |
|
|
|